New RAF-targeted therapeutic shows early promise against tumours with BRAF and RAS mutations

MINDACT breast cancer clinical trial: First results and impact on future trial design

Non-coding mutations driving chronic lymphocytic leukaemia

Comparison of three different PD-L1 diagnostic tests shows a high degree of concordance

Next-generation sequencing in the lymphoid malignancies

Mutational clonality and intratumour heterogeneity as biomarkers for cancer immunotherapy

Retroviral replicating vectors for cancer-targeted gene therapy and immunotherapy

NY-ESO-1 immunotherapy for ovarian cancer

Imaging tumour habitats - life at the edge

Normal and neoplastic stem cells

WIN 2016: Preview of themes

WIN 2016: Preview of Speakers